Dataset Information

CDCA8 as an independent predictor for a poor prognosis in liver cancer.

ABSTRACT:

Background

Human cell division cycle associated 8 (CDCA8) a key regulator of mitosis, has been described as a potential prognostic biomarker for a variety of cancers, such as breast, colon and lung cancers. We aimed to evaluate the potential role of CDCA8 expression in the prognosis of liver cancer by analysing data from The Cancer Genome Atlas (TCGA).

Methods

The Wilcoxon rank-sum test was used to compare the difference in CDCA8 expression between liver cancer tissues and matched normal tissues. Then, we applied logistic regression and the Wilcoxon rank-sum test to identify the association between CDCA8 expression and clinicopathologic characteristics. Cox regression and the Kaplan-Meier method were used to examine the clinicopathologic features correlated with overall survival (OS) in patients from the TCGA. Gene set enrichment analysis (GSEA) was performed to explore possible mechanisms of CDCA8 according to the TCGA dataset.

Results

CDCA8 expression was higher in liver cancer tissues than in matched normal tissues. Logistic regression and the Wilcoxon rank-sum test revealed that the increased level of CDCA8 expression in liver cancer tissues was notably related to T stage (OR?=?1.64 for T1/2 vs. T3/4), clinical stage (OR?=?1.66 for I/II vs. III/IV), histologic grade (OR?=?6.71 for G1 vs. G4) and histological type (OR?=?0.24 for cholangiocarcinoma [CHOL] vs. hepatocellular carcinoma [LIHC]) (all P-values?-6). Univariate analysis showed that high CDCA8 expression was associated with poor OS in liver cancer patients, with a hazard ratio (HR) of 1.85 (95% confidence interval [CI]: 1.47-2.32; P?=?1.16?×?10^-7). Multivariate analysis showed that CDCA8 expression was independently correlated with OS (HR?=?1.74; CI: 1.25-12.64; P?=?1.27?×?10^-5). GSEA revealed that the apoptosis, cell cycle, ErbB, MAPK, mTOR, Notch, p53 and TGF-? signaling pathways were differentially enriched in the CDCA8 high expression phenotype.

Conclusions

High CDCA8 expression is a potential molecular predictor of a poor prognosis in liver cancer.

SUBMITTER: Shuai Y

PROVIDER: S-EPMC7938604 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

CDCA8 as an independent predictor for a poor prognosis in liver cancer.

Shuai Yu Y Fan Erxi E Zhong Qiuyue Q Chen Qiying Q Feng Guangyong G Gou Xiaoxia X Zhang Guihai G

Cancer cell international 20210308 1

<h4>Background</h4>Human cell division cycle associated 8 (CDCA8) a key regulator of mitosis, has been described as a potential prognostic biomarker for a variety of cancers, such as breast, colon and lung cancers. We aimed to evaluate the potential role of CDCA8 expression in the prognosis of liver cancer by analysing data from The Cancer Genome Atlas (TCGA).<h4>Methods</h4>The Wilcoxon rank-sum test was used to compare the difference in CDCA8 expression between liver cancer tissues and matched ...[more]

PMID: 33685433

Similar Datasets

Project description:Background:Bladder cancer is one of the most common urinary malignancies. This study is aimed at providing some promising molecular biomarkers for bladder cancer (BC) by investigating the correlation between C1QTNF6 expression and clinical characteristics as well as prognosis in patients with bladder cancer. Methods:Sequencing profiles of C1QTNF6 mRNA in BC patients were collected to evaluate the distinctive gene expression, between normal bladder mucosa and BC, according to the TCGA and GEO databases. The association between C1QTNF6 expression and the clinical features as well as the disease prognosis was evaluated using two independent cohorts. The expression of C1QTNF6 in normal bladder and BC cells was examined by western blotting and PCR, so the underlying molecular mechanism could be further investigated. Results:C1QTNF6 mRNA levels were found to be differentially expressed in two independent public cohorts, including the TCGA database and GSE13507 dataset from GEO. The protein and RNA levels of C1QTNF6 in BC cells were both elevated when compared to normal bladder cell lines. High C1QTNF6 expression was detected in advanced T/M stages, pathological grade, and AJCC stage when compared to the low C1QTNF6 expression group. The underlying mechanism related to this differential expression could be explained by cell migration and invasion assays, where bladder cancer cells 5637 and T24 had a significant reduction on migration and invasion ability upon knockdown of C1QTNF6 expression. The low C1QTNF6 expression group presented a more prominent OS advantage over the high-expression group in both TCGA and GSE13507 cohorts. Moreover, the protein content in tissues was further validated using the HPA database and TMA. Survival analyses also indicated that the high C1QTNF6 expression group had an unfavorable OS when compared to the low-expression group. Conclusions:High C1QTNF6 expression may serve as a predictor of poor prognosis in bladder cancer patients, and the underlying mechanism is possibly associated with changes on cancer cell migration and invasion ability.

Dataset Information

CDCA8 as an independent predictor for a poor prognosis in liver cancer.

Background

Methods

Results

Conclusions

Publications

CDCA8 as an independent predictor for a poor prognosis in liver cancer.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure